KRM-191

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameKRM-191
Drug Alias NameKRM-191
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlycogen synthase kinase-3 beta inhibitors
TargetsGlycogen synthase kinase-3 beta
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKorea Research Institute Of Chemical Technology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKorea Research Institute Of Chemical Technology
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A